A detailed history of Headlands Technologies LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 5,828 shares of EBS stock, worth $50,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,828
Previous 142,155 95.9%
Holding current value
$50,120
Previous $969,000 95.05%
% of portfolio
0.01%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.72 - $14.77 $779,790 - $2.01 Million
-136,327 Reduced 95.9%
5,828 $48,000
Q2 2024

Aug 07, 2024

BUY
$1.86 - $6.98 $264,408 - $992,241
142,155 New
142,155 $969,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $429M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.